COCH Stock Summary and Trading Ideas (Envoy Medical - Class A | NASDAQ:COCH)

Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.

Envoy Medical - Class A trades on the NASDAQ stock market under the symbol COCH.

As of July 2, 2026, COCH stock price declined to $0.75 with 203,647 million shares trading.

COCH has a beta of 1.43, meaning it tends to be more sensitive to market movements. COCH has a correlation of 0.04 to the broad based SPY ETF.

COCH has a market cap of $57.92 million. This is considered a Micro Cap stock.

Last quarter Envoy Medical - Class A reported $39,000 in Revenue and -$.08 earnings per share. This fell short of revenue expectation by $-21,000 and exceeded earnings estimates by $.06.

The top ETF exchange traded funds that COCH belongs to (by Net Assets): VXF, VTI.

COCH has underperformed the market in the last year with a return of -49.9%, while the SPY ETF gained +21.3%. In the last 3 month period, COCH fell short of the market, returning +0.6%, while SPY returned +13.9%. However, in the most recent 2 weeks COCH has outperformed the stock market by returning +18.6%, while SPY returned -0.3%.

COCH support price is $.74 and resistance is $.84 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that COCH shares will trade within this expected range on the day.